Transcription of Faculty of Sexual & Reproductive Healthcare Clinical Guidance
{{id}} {{{paragraph}}}
Faculty of Sexual & Reproductive HealthcareClinical GuidanceFACULTYOF Sexual &REPRODUCTIVEHEALTHCAREP rogestogen-only PillsClinical Effectiveness Unit March 2015 (Amended April 2019) ISSN 1755-103 XPublished by th e Faculty of Sexual & Reproductive HealthcareRegistered in England No. 2804213 and Registered Charity No. 1019969 First published in 2015 (Updated April 2019)Copyright Faculty of Sexual & Reproductive Healthcare 2015 Permission granted to reproduce fo r personal an d educational use only. Commercial copying, hiring an d lending ar e reference numberTitleAuthor/publisherPublication dateDescription/descriptorsCross referencesSuperseded documentsUpdate/amendment levelReview date01/FSRH/POP/2015 Progestogen-only PillsFaculty of Sexual & Reproductive Healthcare (FSRH)March 2015 (Amended April 2019)
A comparative trial of the DSG versus LNG-only pill reported an overall failure rate for the LNG pill of 1.55 per 100 woman-years [95% confidence interval (CI) 0.422–3.963] and for the DSG pill 0.41 per 100 woman-years (95% CI 0.085–1.204). The failure rates were not found to be
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}